Carl Zeiss Meditec (ETR:AFX) “Neutral” Rating Reconfirmed Today By Independent Research GmbH; The Target is EUR 28.00

Share

Carl Zeiss Meditec (ETR:AFX) Rating Reaffirmed

Recently, In a recent report revealed to investors and clients on Friday, 18 December, Carl Zeiss Meditec (ETR:AFX) shares have had their “Neutral” Rating kept steady by investment advisers at Independent Research GmbH, who currently has a EUR 28.00 target price on firm. This target by Independent Research GmbH suggests the possibile upside of 1.86% from the stock price.

From a total of 7 analysts covering Carl Zeiss Meditec (ETR:AFX) stock, 4 rate it a ”Buy”, 1 a “Sell”, and 2 a ”Hold”. This means that 57% of the ratings are positive. The highest target price is €29 while the lowest target price is €19.80. The mean of all analyst targets is €26.29 with a -3.98% below today’s (€27.38) stock price. Carl Zeiss Meditec was the topic of 10 analyst reports since August 7, 2015 according to the firm StockzIntelligence Inc. Jefferies downgraded shares on December 17 to “Underperform” rating. Independent Research maintained shares with “Hold” rating and €26 target share price in a report from an August 12. Landesbank upgraded AFX stock in a recent report from October 13 to “Buy” rating. Kepler Cheuvreux upgraded the rating on August 7. Kepler Cheuvreux has a “Buy” rating and a €28 price target on shares. Finally, Berenberg upgraded the stock to “Buy” rating in a report issued on a September 15.

The stock increased 0.26% or EUR 0.07 on December 17, striking EUR 27.38. Approximately 87,171 shares of stock traded hands or 118.03% up from the average. Carl Zeiss Meditec AG (ETR:AFX) has declined 6.80% since May 21, 2015 and is downtrending. It has underperformed by 4.54% the S&P500.

Carl Zeiss Meditec (ETR:AFX)

Carl Zeiss Meditec AG is a Germany-based medical technology solutions supplier. The company has a market cap of 2.08 billion EUR. The Firm operates, along with its subsidiaries, in two business areas: Ophthalmology and Microsurgery. It has 32.12 P/E ratio. The Ophthalmology business area is subdivided into two business units: the Ophthalmology systems unit covers a range of laser and diagnostic systems for ophthalmology, and the Surgical Ophthalmology unit combines the Company’s activities in the field of ophthalmic implants and disposables.

COMMENTS: